View full size
Zapraszamy do odwiedzenia nas podczas jubileuszowej 20. edycji konferencji naukowej RANK 2026, która odbędzie się w dniach 18–19 marca w Pardubicach, w klubie ABC. Konferencja jest organizowana przez ...
Czytaj więcejWe are pleased to announce our participation in the prestigious XXXV. Izakovič Memorial 2025, which will take place on October 8–10, 2025 at the Grandhotel Praha, Tatranská Lomnica. The Izakovič Memo...
Czytaj więcejIn the spring, we will participate in the 1st Czechoslovak Congress of Medical Genetics, which will take place from April 2–4, 2025, at the Cultural and Congress Center Elektra in the spa town of Luha...
Czytaj więcej
View full size
Description
ApoA1 (Apolipoprotein A1) is synthesized in the liver and small intestine, and is the major protein component of high density lipoprotein (HDL) in the plasma. ApoA1 has a unique ability to capture and solubilize free cholesterol, and promotes cholesterol efflux from tissues to the liver for excretion. The process, called reverse cholesterol transport, is thought to inhibit atherogenesis. The recombinant human ApoA1 consists of 244 amino acids and predicts a molecular mass of 28.2 KD.
Applications
miRNA in vivo delivery
HDL Assembly
Evaluation of risk for atherosclerotic cardiovascular disease
Source: Human
Expression System: E. coli
Tag: N-terminal His-tag
Purity: >95% as determined by SDS-PAGE
Endotoxin Level: Less than 0.1EU/ug by LAL method
Recommended Storage Condition: -20°C
Expiration date: 12 months